1. Cancer stem cells: Regulation programs, immunological properties and immunotherapy
    Dingxiao Zhang et al, 2018, Seminars in Cancer Biology CrossRef
  2. The metabolic addiction of cancer stem cells
    Om Saswat Sahoo et al, 2022, Frontiers in Oncology CrossRef
  3. The roles of the SOX2 protein in the development of esophagus and esophageal squamous cell carcinoma, and pharmacological target for therapy
    Jiaying Zhang et al, 2023, Biomedicine & Pharmacotherapy CrossRef
  4. Molecular characterization of AwSox2 from bivalveAnodonta woodiana: Elucidating its player in the immune response
    Xichao Xia et al, 2020, Innate Immunity CrossRef
  5. Specific targeting of cancer stem cells by immunotherapy: A possible stratagem to restrain cancer recurrence and metastasis
    Deepti Singh et al, 2022, Biochemical Pharmacology CrossRef
  6. A dynamic mode of mitotic bookmarking by transcription factors
    Sheila S Teves et al, 2016, eLife CrossRef
  7. SOX2 immunity and tissue resident memory in children and young adults with glioma
    Juan C. Vasquez et al, 2017, Journal of Neuro-Oncology CrossRef
  8. Personalized and targeted therapy of esophageal squamous cell carcinoma: an update
    Yongjing Liu et al, 2016, Annals of the New York Academy of Sciences CrossRef
  9. The tale of SOX2: Focusing on lncRNA regulation in cancer progression and therapy
    Peng Huang et al, 2024, Life Sciences CrossRef
  10. Trial watch: Naked and vectored DNA-based anticancer vaccines
    Norma Bloy et al, 2015, OncoImmunology CrossRef
  11. Stem Cell Antigens in Cancer
    Madhav V. Dhodapkar, 2016, Encyclopedia of Immunobiology CrossRef
  12. Immune checkpoint blockade combined with IL‐6 and TGF‐β inhibition improves the therapeutic outcome of mRNA‐based immunotherapy
    Lukasz Bialkowski et al, 2018, International Journal of Cancer CrossRef
  13. Non-immune cell components in tumor microenvironment influencing lung cancer Immunotherapy
    Jingtao Zhang et al, 2023, Biomedicine & Pharmacotherapy CrossRef
  14. LncRNA PCAT1 activates SOX2 and suppresses radioimmune responses via regulating cGAS/STING signalling in non‐small cell lung cancer
    Yanping Gao et al, 2022, Clinical and Translational Medicine CrossRef
  15. Sex-determining Region of Y Chromosome-related High-mobility-group Box 2 in Malignant Tumors
    Shi-Guang Cao et al, 2015, Chinese Medical Journal CrossRef
  16. Designing a novel SOX9 based multi-epitope vaccine to combat metastatic triple-negative breast cancer using immunoinformatics approach
    HemaNandini Rajendran Krishnamoorthy et al, 2023, Molecular Diversity CrossRef
  17. SOX2 regulates multiple malignant processes of breast cancer development through the SOX2/miR-181a-5p, miR-30e-5p/TUSC3 axis
    Kuancan Liu et al, 2017, Molecular Cancer CrossRef
  18. Cationic lipoplexes for treatment of cancer stem cell-derived murine lung tumors
    Terrick Andey et al, 2019, Nanomedicine: Nanotechnology, Biology and Medicine CrossRef
  19. SOX2 and cancer: current research and its implications in the clinic
    Kasia Weina et al, 2014, Clinical and Translational Medicine CrossRef
  20. Combined Cancer Immunotherapy Against Aurora Kinase A
    Iva Kaštánková et al, 2016, Journal of Immunotherapy CrossRef
  21. Radiation and Anti-Cancer Vaccines: A Winning Combination
    Alexandra Cadena et al, 2018, Vaccines CrossRef
  22. Immunotherapy: Newer Therapeutic Armamentarium against Cancer Stem Cells
    Saurabh Pratap Singh et al, 2020, Journal of Oncology CrossRef